Leef Brands (LEEEF) Debt Ratio (2024 - 2026)

Leef Brands (LEEEF) reported Debt Ratio of 0.25 for Q1 2026, down 16.85% sequentially from 0.31 in Q4 2025.

Leef Brands (LEEEF) Debt Ratio (2024 - 2026) Analysis & Trends

Leef Brands (LEEEF) has 3 years of Debt Ratio data on file, last reported at 0.25 in Q1 2026.

  • For the quarter ending Q1 2026, Debt Ratio changed N/A year-over-year to 0.25; the trailing twelve-month figure through Mar 2026 stood at 0.25 (changed N/A YoY), and the FY2025 full-year result was 0.31, up 18.49% from the prior year.
  • Debt Ratio declined to 0.25 in Q1 2026, from 0.31 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.31 in Q4 2025 to a low of 0.25 in Q1 2026.
  • A 3-year average of 0.27 and a median of 0.26 in 2024 frame the typical range for Debt Ratio.
  • Peak annual rise in Debt Ratio reached 18.49% in 2025, while the deepest fall reached 18.49% in 2025.
  • Tracing LEEEF's Debt Ratio over 3 years: stood at 0.26 in 2024, then climbed by 18.49% to 0.31 in 2025, then slipped by 16.85% to 0.25 in 2026.
  • Business Quant data shows LEEEF's Debt Ratio at 0.25 in Q1 2026, 0.31 in Q4 2025, and 0.26 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 0.26
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 0.42
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 0.60
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 0.29
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 0.10
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 0.39
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 0.29
10 Leef Brands 51.94 Mn 46.18 Mn 4.62 Mn 0.25

Historic Data

Download Data
DateValue
Mar 31, 2026 0.25
Dec 31, 2025 0.31
Dec 31, 2024 0.26